NanoPharmaceuticals
Troy, US · Founded 2013 · Delaware LLC
Founders & leadership
NanoPharmaceuticals was founded in 2013 by Shaker Mousa.
SM
Shaker MousaFounder
EM
Eliza McKinneyExecutive
CW
Carl WalkeyExecutive
MJ
Michael J. RosenthalExecutive
TG
T. Gregory DeweyExecutive
EP
Eliza ParkerExecutive
JG
James GozzoExecutive
PD
Paul DavisNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 4 rounds · 2013–2025
▶$622.5KraisedFeb 2025 · 12 investors · PharmaceuticalsRule 506(b)
▶$622.5KraisedFeb 2025 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Paul DavisDirector
- Eliza McKinneyExecutive Officer
- Carl WalkeyExecutive Officer
- Shaker MousaDirector
- Offering amount
- $2.4M
- Amount sold
- $622.5K
- Minimum investment
- $1
- First sale
- Jan 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedAug 2018 · 8 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedAug 2018 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- T. Gregory DeweyDirector
- Eliza J. ParkerExecutive Officer
- Shaker A. MousaExecutive Officer, Director
- Michael J. RosenthalExecutive Officer, Director
- Paul DavisExecutive Officer, Director
- Amount sold
- $1.3M
- First sale
- Aug 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2MraisedApr 2017 · 16 investors · PharmaceuticalsRule 506(b)
▶$2MraisedApr 2017 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. RosenthalExecutive Officer, Director
- T. Gregory DeweyExecutive Officer, Director
- Paul DavisExecutive Officer, Director
- Shaker A. MousaExecutive Officer, Director
- Eliza ParkerExecutive Officer
- Amount sold
- $2M
- First sale
- Apr 2017
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$2.6MraisedFeb 2014 · 13 investors · PharmaceuticalsRule 506(b)
▶$2.6MraisedFeb 2014 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Eliza ParkerExecutive Officer
- Michael J. RosenthalExecutive Officer, Director
- Paul DavisExecutive Officer, Director
- Shaker A. MousaExecutive Officer, Director
- James GozzoExecutive Officer, Director
- Amount sold
- $2.6M
- First sale
- Nov 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded NanoPharmaceuticals?
- NanoPharmaceuticals was founded by Shaker Mousa in 2013.
- How much funding has NanoPharmaceuticals raised?
- NanoPharmaceuticals has disclosed $6.6M raised across 4 rounds.
- Where is NanoPharmaceuticals headquartered?
- NanoPharmaceuticals is headquartered in Troy, US.